C-20
You've been down the leronlimab road (unless my memory is totally gone), along with Marksch and a few others. You have insight and personal experience to guide you AND you're still here. That's enough for me.
I find a lot of what transpires here as tedious, but I peek in to see if there's any new news. It seems almost like the board is exhausted and waiting for the next actual event.
I agree that just playing footsie with the FDA in the US is primarily a waste of time. Even if the trials had generated the correct P-value I suspect some other objection, or "do this", or "change the dosage" or submit the "RO" results or some other roadblock would magically appear. Janet and crew probably have a little "cheat sheet" of clever detours to send us off into a briar patch of dead ends.
Going outside of the US was the best course and it seems to be getting some traction.
Strange - by supporting Leronlimab we're also providing an "emergency remedy" for those dissing leronlimab. If they had had their way, there'd be no solution if things go south. Sort of short-sighted, but it's also a potential solution for the "white hats" as well. Now, we wait as the different markers are rolled into place.
I'm somewhat pleased that restrictions are rolling back in time for summer, but at the same time very concerned. I hope the US isn't leaving itself vulnerable to the variants coming from regions with overblown numbers of Covid-19ers. My vaccinations are already approaching the six month mark and I wonder how long they will actually remain effective - especially with these new variations. It's disconcerting that leronlimab is NOT EASILY AVAILABLE IN THE US. Back in November, December, and January the folks in India thought they were "out of the woods" and look what has happened there.
Thank you for being here and "staying the course." This virus isn't gone, the FDA is still a marionette show, and thank goodness (despite his shortcomings), Nader hasn't given up. Some day we lift a glass together (or a cup of Rishi Curcumin-Ginger tea, etc.), until then ...it seems you have some other respondents, LOL.
